Product defect: Martindale Pharmaceuticals antibiotic eye drops
The MHRA has notified practitioners of missing braille and an incorrect patient information leaflet within unexpired batches of the eye drops
The Medicines and Healthcare products Regulatory Agency (MHRA) has alerted practitioners to two defects affecting Martindale Pharmaceuticals chloramphenicol 0.5% W/V antibiotic eye drops PL 00156/0109.
Two issues affect all unexpired batches of the product; the braille is missing from the carton and the packs contain an incorrect patient information leaflet.
The MHRA stated that the batches are not being recalled in order to maintain supply.